Please login to the form below

Not currently logged in
Email:
Password:

obesity

This page shows the latest obesity news and features for those working in and with pharma, biotech and healthcare.

Eisai agrees to pull obesity drug Belviq after safety alert

Eisai agrees to pull obesity drug Belviq after safety alert

Weight-loss drug linked to increased risk of cancer. Eisai has moved swiftly to comply with an FDA request to pull its obesity drug Belviq off the market after it was

Latest news

More from news
Approximately 40 fully matching, plus 328 partially matching documents found.

Latest Intelligence

  • Weirdos and misfits Weirdos and misfits

    Meanwhile, obesity continues to increase across the EU with one in six defined as clinically obese.

  • Keeping up the fight against HIV and using the lessons to tackle other threats Keeping up the fight against HIV and using the lessons to tackle other threats

    The data is still evolving but, as obesity grows, fatty liver disease is becoming more common and a more common cause of liver cirrhosis and transplant. ... There is no sign of obesity rates subsiding so, with a close link established between weight and

  • Case study: UK Malnutrition Awareness Week 2018 Case study: UK Malnutrition Awareness Week 2018

    It is hard to persuade the national consumer media to talk about malnutrition as the news agenda is more focused on obesity.

  • 25 Women Leaders in UK Healthcare 25 Women Leaders in UK Healthcare

    It is focusing on four areas of acute medical and societal need where it believes healthcare comms can play a big role: antimicrobial resistance, mental health, obesity and precision medicine.

  • Case study: Sugar-coating a Tax Case study: Sugar-coating a Tax

    Client:Obesity Health Alliance members and Jamie Oliver. Agency:Sustain’s Children’s Food Campaign. ... Yes, childhood obesity is still an incredibly difficult challenge, but we’ve proved that by getting together across the industry we can start to

More from intelligence
Approximately 2 fully matching, plus 33 partially matching documents found.

Latest appointments

  • Novo Nordisk appoints new senior principal clinical scientist Novo Nordisk appoints new senior principal clinical scientist

    Gough will be responsible for providing clinical guidance on the development of new molecules and drugs from early stage through to phase III and beyond for obesity and diabetes.

  • MedImmune appoints Dr Christopher Rhodes MedImmune appoints Dr Christopher Rhodes

    In that position he led a large team of researchers focused on molecular mechanisms that control key functions in the pathogenesis of diabetes and obesity.

  • Anthony Zook resigns as Vivus CEO Anthony Zook resigns as Vivus CEO

    shareholders became unhappy with the way Vivus handled the launch of its obesity drug Qsymia (phentermine/ topiramat). ... This coup was led by investment group First Manhattan Co, which had attempted to replace the entire board of Vivus after Qsymia

  • Roche’s Torsten Hoffmann to join Zealand Pharma Roche’s Torsten Hoffmann to join Zealand Pharma

    In his new role at Zealand, Dr Hoffmann joins a more compact company focused on the discovery of drugs in cardio-metabolic diseases, diabetes and obesity.

  • Burson-Marsteller hires senior DH press officer Burson-Marsteller hires senior DH press officer

    In her previous role, Moore worked with both public health ministers and the chief medical officer, developing proactive and reactive communications strategies for issues including immunisation, genetics, obesity and alcohol.

More from appointments
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest from PMHub

  • Healthanuary? Healthanuary?

    The social and psychological causes that lead to obesity are complex but with the situation at crisis point, obesity is now affecting one in four adults, and even more alarmingly, one ... 2. It is for this reason that Page &Page is raising health

  • Digital therapeutics and their impact on society

    This is in part due to the explosive, bordering on unmanageable, increase in chronic diseases, such as cardiovascular disease, diabetes, Alzheimer’s disease, obesity and asthma.

  • Are supermarkets responsible for public health? Are supermarkets responsible for public health?

    The relationship between poor health – many conditions of which are related to obesity – and socio-economic status is well documented. ... References. 1. Newton S, Braithwaite D, Akinyemiju TF. Socio-economic status over the life course and

  • Language barriers: Obesity has become a loaded word

    feel that saying ‘obesity is bad for your health’ is the same as saying ‘if you are obese you are bad’. ... by psychological research, and that healthcare professionals working in obesity services should have training on the psychology of obesity.

  • Behavioural Science in Healthcare Behavioural Science in Healthcare

    We are bombarded with messages about health, from the global issue of antibiotic resistance to increased obesity and heart disease, every day via every conceivable channel.

More from PMHub
Approximately 4 fully matching, plus 25 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
Pharma M&A
Pharma funding and M&A in 2020
Why pharma M&A has continually bucked the trend...
Behaviour change through medical education: How can we turn aspiration into reality?
Practical, evidence-based insights into a CME process that aims to effect measurable behaviour change...

Infographics